Literature DB >> 1654951

Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle.

K Ohlendieck1, J M Ervasti, K Matsumura, S D Kahl, C J Leveille, K P Campbell.   

Abstract

Dystrophin-related protein (DRP) is an autosomal gene product with high homology to dystrophin. We have used highly specific antibodies to the unique C-terminal peptide sequences of DRP and dystrophin to examine the subcellular localization and biochemical properties of DRP in adult skeletal muscle. DRP is enriched in isolated sarcolemma from control and mdx mouse muscle, but is much less abundant than dystrophin. Immunofluorescence microscopy localized DRP almost exclusively to the neuromuscular junction region in rabbit and mouse skeletal muscle, as well as mdx mouse muscle and denervated mouse muscle. DRP is also present in normal size and abundance and localizes to the neuromuscular junction region in muscle from the dystrophic mouse model dy/dy. Thus, DRP is a junction-specific membrane cytoskeletal protein that may play an important role in the organization of the postsynaptic membrane of the neuromuscular junction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654951     DOI: 10.1016/0896-6273(91)90301-f

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  105 in total

1.  Roles of rapsyn and agrin in interaction of postsynaptic proteins with acetylcholine receptors.

Authors:  C Fuhrer; M Gautam; J E Sugiyama; Z W Hall
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  Comparative proteomic profiling of dystroglycan-associated proteins in wild type, mdx, and Galgt2 transgenic mouse skeletal muscle.

Authors:  Jung Hae Yoon; Eric Johnson; Rui Xu; Laura T Martin; Paul T Martin; Federica Montanaro
Journal:  J Proteome Res       Date:  2012-07-30       Impact factor: 4.466

3.  The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membrane.

Authors:  Armelle Bonet-Kerrache; Mathieu Fortier; Franck Comunale; Cécile Gauthier-Rouvière
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

4.  The development of the myotendinous junction. A review.

Authors:  Benjamin Charvet; Florence Ruggiero; Dominique Le Guellec
Journal:  Muscles Ligaments Tendons J       Date:  2012-09-10

5.  Increased expression of dystrophin, beta-dystroglycan and adhalin in denervated rat muscles.

Authors:  D Biral; L Senter; G Salviati
Journal:  J Muscle Res Cell Motil       Date:  1996-10       Impact factor: 2.698

6.  Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle.

Authors:  D J Law; J G Tidball
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.

Authors:  Paul J Thomas; Rui Xu; Paul T Martin
Journal:  Am J Pathol       Date:  2016-09       Impact factor: 4.307

8.  Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.

Authors:  Christine Péladeau; Aatika Ahmed; Adel Amirouche; Tara E Crawford Parks; Lucas M Bronicki; Vladimir Ljubicic; Jean-Marc Renaud; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2015-10-22       Impact factor: 6.150

9.  Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse.

Authors:  H Xu; P Christmas; X R Wu; U M Wewer; E Engvall
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

10.  Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin.

Authors:  K Matsumura; I Nonaka; F M Tomé; K Arahata; H Collin; F Leturcq; D Récan; J C Kaplan; M Fardeau; K P Campbell
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.